Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
24
OPK Quote, Financials, Valuation and Earnings
Last price:
$1.15
Seasonality move
:
5.16%
Day range:
$1.11 - $1.15
52-week range:
$1.10 - $1.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.43x
P/B ratio:
0.69x
Volume:
1.2M
Avg. volume:
2.6M
1-year change:
-30.91%
Market cap:
$876.8M
Revenue:
$606.9M
EPS (TTM):
-$0.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$130.8M | -$0.07 | -12.79% | -20.56% | $3.40 |
|
ALGN
Align Technology, Inc.
|
$1B | $2.26 | 4.29% | 78.68% | $201.69 |
|
ATRC
AtriCure, Inc.
|
$139.8M | -$0.06 | 12.88% | -57.61% | $47.88 |
|
BSX
Boston Scientific Corp.
|
$5.2B | $0.79 | 11.18% | 75.33% | $100.81 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.6B | $2.13 | 16.31% | 10.98% | $605.08 |
|
KIDS
OrthoPediatrics Corp.
|
$58.3M | -$0.44 | 11.31% | -4.82% | $24.89 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$1.14 | $3.40 | $876.8M | -- | $0.00 | 0% | 1.43x |
|
ALGN
Align Technology, Inc.
|
$170.60 | $201.69 | $12B | 29.79x | $0.00 | 0% | 3.03x |
|
ATRC
AtriCure, Inc.
|
$29.07 | $47.88 | $1.5B | -- | $0.00 | 0% | 2.67x |
|
BSX
Boston Scientific Corp.
|
$62.82 | $100.81 | $94.5B | 32.82x | $0.00 | 0% | 4.74x |
|
ISRG
Intuitive Surgical, Inc.
|
$452.07 | $605.08 | $156.3B | 55.87x | $0.00 | 0% | 15.86x |
|
KIDS
OrthoPediatrics Corp.
|
$16.06 | $24.89 | $400M | -- | $0.00 | 0% | 1.57x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
23.84% | 0.905 | 41.49% | 3.15x |
|
ALGN
Align Technology, Inc.
|
2.75% | -0.073 | 1.03% | 1.16x |
|
ATRC
AtriCure, Inc.
|
13.46% | 1.435 | 3.88% | 2.88x |
|
BSX
Boston Scientific Corp.
|
33.07% | 1.671 | 8.45% | 0.94x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.639 | 0.08% | 3.73x |
|
KIDS
OrthoPediatrics Corp.
|
25.25% | 0.859 | 26.27% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OPK
OPKO Health, Inc.
|
$45M | -$38.3M | -12.93% | -17.23% | -25.81% | -$28.6M |
|
ALGN
Align Technology, Inc.
|
$751.8M | $227.1M | 10.18% | 10.49% | 21.68% | $187.3M |
|
ATRC
AtriCure, Inc.
|
$104.6M | $3.5M | -2.09% | -2.44% | 2.49% | $18.4M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
KIDS
OrthoPediatrics Corp.
|
$39.4M | -$5.5M | -8.89% | -11.31% | -8.94% | $7.7M |
OPKO Health, Inc. vs. Competitors
-
Which has Higher Returns OPK or ALGN?
Align Technology, Inc. has a net margin of -21.06% compared to OPKO Health, Inc.'s net margin of 12.96%. OPKO Health, Inc.'s return on equity of -17.23% beat Align Technology, Inc.'s return on equity of 10.49%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.30.29% -$0.04 $1.7B ALGNAlign Technology, Inc.71.77% $1.89 $4.2B -
What do Analysts Say About OPK or ALGN?
OPKO Health, Inc. has a consensus price target of $3.40, signalling upside risk potential of 198.25%. On the other hand Align Technology, Inc. has an analysts' consensus of $201.69 which suggests that it could grow by 18.23%. Given that OPKO Health, Inc. has higher upside potential than Align Technology, Inc., analysts believe OPKO Health, Inc. is more attractive than Align Technology, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 ALGNAlign Technology, Inc.7 5 0 -
Is OPK or ALGN More Risky?
OPKO Health, Inc. has a beta of 1.493, which suggesting that the stock is 49.294% more volatile than S&P 500. In comparison Align Technology, Inc. has a beta of 1.812, suggesting its more volatile than the S&P 500 by 81.239%.
-
Which is a Better Dividend Stock OPK or ALGN?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Align Technology, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or ALGN?
OPKO Health, Inc. quarterly revenues are $148.5M, which are smaller than Align Technology, Inc. quarterly revenues of $1B. OPKO Health, Inc.'s net income of -$31.3M is lower than Align Technology, Inc.'s net income of $135.8M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Align Technology, Inc.'s PE ratio is 29.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.43x versus 3.03x for Align Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.43x -- $148.5M -$31.3M ALGNAlign Technology, Inc.3.03x 29.79x $1B $135.8M
-
Which has Higher Returns OPK or ATRC?
AtriCure, Inc. has a net margin of -21.06% compared to OPKO Health, Inc.'s net margin of 1.25%. OPKO Health, Inc.'s return on equity of -17.23% beat AtriCure, Inc.'s return on equity of -2.44%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.30.29% -$0.04 $1.7B ATRCAtriCure, Inc.74.43% $0.04 $568.4M -
What do Analysts Say About OPK or ATRC?
OPKO Health, Inc. has a consensus price target of $3.40, signalling upside risk potential of 198.25%. On the other hand AtriCure, Inc. has an analysts' consensus of $47.88 which suggests that it could grow by 64.69%. Given that OPKO Health, Inc. has higher upside potential than AtriCure, Inc., analysts believe OPKO Health, Inc. is more attractive than AtriCure, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 ATRCAtriCure, Inc.4 2 0 -
Is OPK or ATRC More Risky?
OPKO Health, Inc. has a beta of 1.493, which suggesting that the stock is 49.294% more volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.430, suggesting its more volatile than the S&P 500 by 43.012%.
-
Which is a Better Dividend Stock OPK or ATRC?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or ATRC?
OPKO Health, Inc. quarterly revenues are $148.5M, which are larger than AtriCure, Inc. quarterly revenues of $140.5M. OPKO Health, Inc.'s net income of -$31.3M is lower than AtriCure, Inc.'s net income of $1.8M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.43x versus 2.67x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.43x -- $148.5M -$31.3M ATRCAtriCure, Inc.2.67x -- $140.5M $1.8M
-
Which has Higher Returns OPK or BSX?
Boston Scientific Corp. has a net margin of -21.06% compared to OPKO Health, Inc.'s net margin of 12.68%. OPKO Health, Inc.'s return on equity of -17.23% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.30.29% -$0.04 $1.7B BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About OPK or BSX?
OPKO Health, Inc. has a consensus price target of $3.40, signalling upside risk potential of 198.25%. On the other hand Boston Scientific Corp. has an analysts' consensus of $100.81 which suggests that it could grow by 60.48%. Given that OPKO Health, Inc. has higher upside potential than Boston Scientific Corp., analysts believe OPKO Health, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 BSXBoston Scientific Corp.24 0 0 -
Is OPK or BSX More Risky?
OPKO Health, Inc. has a beta of 1.493, which suggesting that the stock is 49.294% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.926%.
-
Which is a Better Dividend Stock OPK or BSX?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or BSX?
OPKO Health, Inc. quarterly revenues are $148.5M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. OPKO Health, Inc.'s net income of -$31.3M is lower than Boston Scientific Corp.'s net income of $670M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 32.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.43x versus 4.74x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.43x -- $148.5M -$31.3M BSXBoston Scientific Corp.4.74x 32.82x $5.3B $670M
-
Which has Higher Returns OPK or ISRG?
Intuitive Surgical, Inc. has a net margin of -21.06% compared to OPKO Health, Inc.'s net margin of 27.89%. OPKO Health, Inc.'s return on equity of -17.23% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.30.29% -$0.04 $1.7B ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About OPK or ISRG?
OPKO Health, Inc. has a consensus price target of $3.40, signalling upside risk potential of 198.25%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $605.08 which suggests that it could grow by 33.85%. Given that OPKO Health, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe OPKO Health, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 ISRGIntuitive Surgical, Inc.17 9 1 -
Is OPK or ISRG More Risky?
OPKO Health, Inc. has a beta of 1.493, which suggesting that the stock is 49.294% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.677, suggesting its more volatile than the S&P 500 by 67.7%.
-
Which is a Better Dividend Stock OPK or ISRG?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or ISRG?
OPKO Health, Inc. quarterly revenues are $148.5M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. OPKO Health, Inc.'s net income of -$31.3M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 55.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.43x versus 15.86x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.43x -- $148.5M -$31.3M ISRGIntuitive Surgical, Inc.15.86x 55.87x $2.9B $799.5M
-
Which has Higher Returns OPK or KIDS?
OrthoPediatrics Corp. has a net margin of -21.06% compared to OPKO Health, Inc.'s net margin of -16.4%. OPKO Health, Inc.'s return on equity of -17.23% beat OrthoPediatrics Corp.'s return on equity of -11.31%.
Company Gross Margin Earnings Per Share Invested Capital OPKOPKO Health, Inc.30.29% -$0.04 $1.7B KIDSOrthoPediatrics Corp.63.92% -$0.43 $463.7M -
What do Analysts Say About OPK or KIDS?
OPKO Health, Inc. has a consensus price target of $3.40, signalling upside risk potential of 198.25%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.89 which suggests that it could grow by 54.97%. Given that OPKO Health, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe OPKO Health, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings OPKOPKO Health, Inc.2 2 0 KIDSOrthoPediatrics Corp.5 1 0 -
Is OPK or KIDS More Risky?
OPKO Health, Inc. has a beta of 1.493, which suggesting that the stock is 49.294% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.162, suggesting its more volatile than the S&P 500 by 16.171%.
-
Which is a Better Dividend Stock OPK or KIDS?
OPKO Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. OPKO Health, Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OPK or KIDS?
OPKO Health, Inc. quarterly revenues are $148.5M, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.6M. OPKO Health, Inc.'s net income of -$31.3M is lower than OrthoPediatrics Corp.'s net income of -$10.1M. Notably, OPKO Health, Inc.'s price-to-earnings ratio is -- while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for OPKO Health, Inc. is 1.43x versus 1.57x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OPKOPKO Health, Inc.1.43x -- $148.5M -$31.3M KIDSOrthoPediatrics Corp.1.57x -- $61.6M -$10.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
